Mirae Asset Global Investments »

Enliven Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $170k 12k 13.84
2023-09-30 $154k 11k 13.66
2023-06-30 $230k 11k 20.41